Pfizer Limited has informed the Exchange regarding a press release dated August 11, 2025, titled ""Pfizer Launches 20-valent Pneumococcal Conjugate Vaccine (PCV20) for Adults in India, Offering Broad Protection Against Pneumococcal Disease"".